Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInventory AverageNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on Sales

Cresco Labs (CRLBF) EBITDA Margin (2020 - 2025)

Historic EBITDA Margin for Cresco Labs (CRLBF) over the last 6 years, with Q3 2025 value amounting to 13.46%.

  • Cresco Labs' EBITDA Margin fell 92800.0% to 13.46% in Q3 2025 from the same period last year, while for Sep 2025 it was 9.7%, marking a year-over-year decrease of 50700.0%. This contributed to the annual value of 10.43% for FY2024, which is 128700.0% up from last year.
  • Cresco Labs' EBITDA Margin amounted to 13.46% in Q3 2025, which was down 92800.0% from 8.11% recorded in Q2 2025.
  • Cresco Labs' EBITDA Margin's 5-year high stood at 172.71% during Q1 2021, with a 5-year trough of 122.52% in Q3 2021.
  • Moreover, its 5-year median value for EBITDA Margin was 4.19% (2024), whereas its average is 5.15%.
  • Per our database at Business Quant, Cresco Labs' EBITDA Margin skyrocketed by 8210500bps in 2021 and then plummeted by -1632500bps in 2022.
  • Cresco Labs' EBITDA Margin (Quarter) stood at 7.14% in 2021, then plummeted by -1106bps to 71.89% in 2022, then soared by 120bps to 14.4% in 2023, then crashed by -157bps to 8.14% in 2024, then plummeted by -65bps to 13.46% in 2025.
  • Its last three reported values are 13.46% in Q3 2025, 8.11% for Q2 2025, and 9.18% during Q1 2025.